Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review

Chronic Kidney Disease: A Life Course Health Development Perspective

In: Handbook of Life Course Health Development [Internet]. Cham (CH): Springer; 2018.
.
Affiliations
Free Books & Documents
Review

Chronic Kidney Disease: A Life Course Health Development Perspective

Patrick D. Brophy et al.
Free Books & Documents

Excerpt

Chronic kidney disease (CKD) reflects life events that range from maternal-fetal influences to geriatric exposures. The global direct and indirect costs of CKD are high and include maternal-neonatal hospitalization and treatment, acute kidney injury, dialysis and transplant, missed work, and medications, to name a few. The impact of poor diet, adverse childhood experiences, medication use, and failure to follow consistent public health standards are increasingly appreciated as key influences in the development of CKD. Socioeconomic factors can significantly influence the timing and phenotypic expression in people at risk for developing CKD, although more research is needed to understand these mechanisms. In general, biomedicine has been focused on treating well-established CKD morbidity. This strategy has been short sighted and costly. A more cost-effective approach would focus on early life interventions that hold the potential for mitigating CKD risk and its sequelae. This chapter applies the life course health development principles to review determinants and pathways for CKD evolution and identifies of the gaps in our knowledgebase. We also discuss several research strategies for evaluating the life course health development of CKD.

PubMed Disclaimer

References

    1. Abdel-Hakeem, A. K., Henry, T. Q., Magee, T. R., Desai, M., Ross, M. G., Mansano, R. Z., et al. (2008). Mechanisms of impaired nephrogenesis with fetal growth restriction: Altered rena transcription and growth factor expression. American Journal of Obstetrics and Gynecology, 199(3), 252 e1–252 e7. - PMC - PubMed
    1. Ardissino, G., Vigano, S., Testa, S., Dacco, V., Paglialonga, F., Leoni, A., et al. (2007). No clear evidence of ACEi efficacy on the progression of chronic kidney disease in children with hypodysplastic nephropathy--report from the ItalKid project database. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association., 22(9), 2525–2530. - PubMed
    1. Askenazi, D. J., Koralkar, R., Hundley, H. E., Montesanti, A., Parwar, P., Sonjara, S., & Ambalavanan, N. (2012). Urine biomarkers predict acute kidney injury in newborns. The Journal of Pediatrics, 161(2), 270–275. - PMC - PubMed
    1. Atkinson, M. A., Pierce, C. B., Zack, R. M., et al. (2010a). Hemoglobin differences by race in children with CKD. American Journal of Kidney Diseases, 55(6), 1009–1017. - PMC - PubMed
    1. Atkinson, M. A., Martz, K., Warady, B. A., & Neu, A. M. (2010b). Risk for anemia in pediatric chronic kidney disease patients: A report of NAPRTCS. Pediatric Nephrology, 25(9), 1699–1706. - PubMed

LinkOut - more resources